What is OSSIO?
OSSIO is at the forefront of orthopedic innovation, developing and commercializing its proprietary OSSIOfiber® technology. This advanced material is engineered to support natural bone regeneration, offering a compelling alternative to traditional metal implants by avoiding the need for permanent hardware. The company's product portfolio includes a range of solutions such as suture anchors, fixation nails, and hammertoe fixation systems, all designed to enhance patient outcomes and recovery experiences. By utilizing implant materials that mimic natural bone minerals, OSSIO aims to provide a stronger, more integrated healing process, thereby reducing the complications and patient dissatisfaction often associated with metal implants.
How much funding has OSSIO raised?
OSSIO has raised a total of $138.1M across 4 funding rounds:
Series A
$22M
Series C
$38.5M
Private Equity
$27.6M
Debt
$50M
Series A (2019): $22M, investors not publicly disclosed
Series C (2022): $38.5M led by MVM Partners
Private Equity (2024): $27.6M supported by MVM Partners, Courage Capital Management, Questa Capital, and OCV Partners
Debt (2026): $50M featuring Horizon Technology Finance and Monroe Capital
Key Investors in OSSIO
MVM Partners
MVM Partners LLP invests in innovative healthcare companies, actively supporting businesses that enhance healthcare delivery through quality and cost-effective solutions. With teams based in Boston, London, and the San Francisco Bay Area, MVM's focus spans various sectors including medical technology, pharmaceuticals, and digital health. The firm partners with management teams to drive growth and establish new medical standards, aiming to address significant unmet needs in large addressable markets. Founded in 1997, MVM has built a portfolio of companies and has extensive experience guiding them through successful exits.
Courage Capital Management
Courage Capital Management, founded in 1998, specializes in managing private funds for institutional investors and family offices with a focus on three investment strategies: Healthcare Investing, Music Rights Acquisitions, and Small Business Financing. The firm is led by experienced professionals, including founder Richard Patton and President Tom Milne, who bring extensive backgrounds in finance and investment management. Courage Capital aims to provide tailored investment solutions to its clients, leveraging its expertise in various sectors.
Questa Capital
Questa Capital invests in innovative healthcare companies that aim to enhance patient experiences, reduce costs, and improve overall population health. They partner with exceptional teams to support the development of next-generation healthcare solutions, such as connected AEDs, telemedicine for opioid recovery, and advanced neurological therapies for children. Their portfolio includes companies like Avive, Bicycle Health, Calyxo, ClaritasRx, Cortica, and DispatchHealth, each focused on transforming healthcare delivery.
What's next for OSSIO?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for OSSIO. This capital infusion is expected to accelerate the company's market penetration, further research and development into its OSSIOfiber® technology, and potentially expand its product offerings. With a clear focus on improving orthopedic care and patient recovery, OSSIO is well-positioned to capitalize on its technological advantages. The company's trajectory suggests a strategic move towards scaling operations and solidifying its market leadership in the bone healing solutions sector, potentially paving the way for future commercial milestones or strategic partnerships.
See full OSSIO company page
